ACON
Aclarion Inc
NASDAQ: ACON · HEALTHCARE · HEALTH INFORMATION SERVICES
$3.26
-3.26% today
Updated 2026-04-29
Market cap
$8.03M
P/E ratio
—
P/S ratio
105.99x
EPS (TTM)
$-13.61
Dividend yield
—
52W range
$2 – $12
Volume
0.1M
Aclarion Inc (ACON) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $26897.00 | $48652.00 | $60292.00 | $60444.00 | $75404.00 | $45724.00 | $75730.00 |
| Revenue growth (YoY) | — | +80.9% | +23.9% | +0.3% | +24.8% | -39.4% | +65.6% |
| Cost of revenue | $63180.00 | $66245.00 | $69175.00 | $65298.00 | $75728.00 | $129767.00 | $296308.00 |
| Gross profit | $-36283.00 | $-17593.00 | $-8883.00 | $-4854.00 | $-324.00 | $-84043.00 | $-220578.00 |
| Gross margin | -134.9% | -36.2% | -14.7% | -8.0% | -0.4% | -183.8% | -291.3% |
| R&D | $1.74M | $1.05M | $787850.00 | $1.07M | $873336.00 | $888767.00 | $1.03T |
| SG&A | $1.59M | $1.07M | $1.83M | $3.99M | $3.25M | $3.61M | $4.12T |
| Operating income | $-4.01M | $-4.48M | $-2.95M | $-5.56M | $-4.88M | $-5.51M | $-7.05M |
| Operating margin | -14921.0% | -9203.0% | -4897.9% | -9201.2% | -6466.5% | -12057.2% | -9312.5% |
| EBITDA | $-3.84M | $-4.28M | $-4.29M | $-5.42M | $-4.14M | $-6.26M | $-6.82M |
| EBITDA margin | -14262.0% | -8803.1% | -7111.1% | -8962.7% | -5491.0% | -13700.3% | -9012.3% |
| EBIT | $-4.01M | $-4.48M | $-4.47M | $-5.56M | $-4.30M | $-6.46M | $-7.05M |
| Interest expense | $4995.00 | $156059.00 | $476479.00 | $1.51M | $608288.00 | $535470.00 | $0.00 |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-4.02M | $-4.64M | $-4.95M | $-7.07M | $-4.91M | $-6.99M | $-7.23M |
| Net income growth (YoY) | — | -15.3% | -6.8% | -42.8% | +30.5% | -42.4% | -3.4% |
| Profit margin | -14943.1% | -9527.3% | -8210.5% | -11694.4% | -6513.4% | -15293.8% | -9551.9% |